CTRI/2021/07/034933尚未招募未知
To evaluate role of endothelin 1 as marker for severe COVID 19 related disease : An observational cohort pilot study
All india Institute of Medical Science Rishikesh0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •COVID 19 cases confirmed by RTPCR
- •Age greater than 18 years of age
- •Informed consent
排除标准
- •Infection other than COVID
- •Lung malignancy
- •Chronic obstructive Pulmonary disease
- •Chronic renal failure
- •Connective tissue disorders
- •Age greater than 90 years
- •Advanced liver disease
研究者
相似试验
Unknown
不适用
Study on Correlation Between Vascular ET-1 and Adiponectin in Pediatric ObesityEndothelial DysfunctionOBESITYInsulin ResistanceNCT01750333Monica Montagnani60
进行中（未招募）
1 期
Influence of the selective endothelin receptor-blocker Ambrisetan on the portal pressure in patients with cirrhosisPortal hypertension and hepatic cirrhosisMedDRA version: 16.1Level: PTClassification code 10036200Term: Portal hypertensionSystem Organ Class: 10019805 - Hepatobiliary disordersMedDRA version: 16.1Level: LLTClassification code 10009213Term: Cirrhosis of liverSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2007-005679-33-DEMedizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg
进行中（未招募）
1 期
se of endothelin-1 antagonists in patients with Established Pulmonary Hypertension and Fibrotic Lung Disease. – A randomised, placebo-controlled, double-blinded study. - Tracleer in Interstitial Lung Disease and Pulmonary HypertensioPulmonary hypertension in patients with interstitial lung disease.MedDRA version: 9.1 Level: LLT Classification code 10064911 Term: Pulmonary arterial hypertensionEUCTR2007-001643-21-GBRoyal Brompton and Harefield NHS Trust48
招募中
2 期
A Study to Assess the Effects of the Endothelin Receptor Antagonist Zibotentan and the SGLT2 Inhibitor Dapagliflozin in Patients elevated Albuminuria: a Randomized Double Blind Cross-Over Trialdiabetic kidney disease1001265310029149diabetic nephropathyNL-OMON54022niversitair Medisch Centrum Groningen12
进行中（未招募）
1 期
A Study to Assess the Effects of the drugs Zibotentan and Dapagliflozin in Patients with Elevated Levels of Protein in UrinePatients with elevated AlbuminuriaMedDRA version: 21.1Level: PTClassification code 10061835Term: Diabetic nephropathySystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 20.0Level: PTClassification code 10016807Term: Fluid retentionSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.0Level: PTClassification code 10001580Term: AlbuminuriaSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2021-001324-18-NLniversity Medical Center Groningen38